111 Return on Tangible Equity 2018-2024 | YI
Current and historical return on tangible equity values for 111 (YI) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| 111 Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2024-12-31 | $-0.01B | $-0.09B | 10.26% |
| 2024-09-30 | $-0.04B | $-0.09B | 41.74% |
| 2024-06-30 | $-0.05B | $-0.09B | 57.85% |
| 2024-03-31 | $-0.05B | $-0.08B | 70.43% |
| 2023-12-31 | $-0.06B | $-0.08B | 80.58% |
| 2023-09-30 | $-0.04B | $-0.07B | 64.57% |
| 2023-06-30 | $-0.04B | $-0.06B | 71.79% |
| 2023-03-31 | $-0.05B | $-0.06B | 88.07% |
| 2022-12-31 | $-0.06B | $-0.06B | 123.08% |
| 2022-09-30 | $-0.06B | $-0.05B | 160.00% |
| 2022-06-30 | $-0.09B | $-0.05B | 301.69% |
| 2022-03-31 | $-0.10B | $-0.04B | 851.06% |
| 2021-12-31 | $-0.11B | $-0.03B | -1200.00% |
| 2021-09-30 | $-0.11B | $-0.01B | -360.33% |
| 2021-06-30 | $-0.09B | $0.03B | -172.86% |
| 2021-03-31 | $-0.07B | $0.04B | -115.18% |
| 2020-12-31 | $-0.07B | $0.06B | -91.50% |
| 2020-09-30 | $-0.07B | $0.07B | -77.75% |
| 2020-06-30 | $-0.07B | $0.08B | -67.15% |
| 2020-03-31 | $-0.07B | $0.09B | -59.50% |
| 2019-12-31 | $-0.07B | $0.11B | -51.99% |
| 2019-09-30 | $-0.07B | $0.13B | -42.63% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.067B | $1.973B |
| 111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $39.499B | 54.56 |
| Hims & Hers Health (HIMS) | United States | $14.471B | 150.35 |
| Tempus AI (TEM) | United States | $11.278B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.503B | 70.35 |
| IRhythm Technologies (IRTC) | United States | $4.501B | 0.00 |
| Privia Health (PRVA) | United States | $3.050B | 208.50 |
| Enovis (ENOV) | United States | $2.060B | 11.48 |
| Clover Health Investments (CLOV) | United States | $1.807B | 0.00 |
| Schrodinger (SDGR) | United States | $1.722B | 0.00 |
| Phreesia (PHR) | United States | $1.510B | 0.00 |
| Omnicell (OMCL) | United States | $1.310B | 23.11 |
| Azenta (AZTA) | United States | $1.258B | 58.45 |
| 10x Genomics (TXG) | United States | $1.148B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.620B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.581B | 0.00 |
| Talkspace (TALK) | United States | $0.499B | 149.00 |
| Veradigm (MDRX) | United States | $0.455B | 0.00 |
| Claritev (CTEV) | United States | $0.450B | 0.00 |
| Standard BioTools (LAB) | United States | $0.410B | 0.00 |
| TruBridge (TBRG) | United States | $0.376B | 834.67 |
| Health Catalyst (HCAT) | United States | $0.283B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.214B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.197B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.142B | 0.00 |
| Pulmonx (LUNG) | United States | $0.138B | 0.00 |
| American Well (AMWL) | United States | $0.116B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.099B | 0.00 |
| CareCloud (CCLD) | United States | $0.089B | 3.39 |
| Outset Medical (OM) | United States | $0.070B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.057B | 0.00 |
| HeartBeam (BEAT) | United States | $0.052B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.042B | 0.00 |
| Zhongchao (ZCMD) | China | $0.032B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.013B | 0.00 |
| Precipio (PRPO) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |